Jason Wannemacher
Nurse Practitioner · Middletown, OHNPI 1295086551
Payments from drug & device makers
Across 400 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Regeneron Healthcare Solutions, Inc.$525
- Boehringer Ingelheim$451
- Sanofi$328
- Takeda Pharmaceuticals U.S.A., Inc.$305
- plus $2K from 27 others
What the payments were for
- Food & beverage$7,26398%
- Education$1172%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 142 | $1,874 |
| AstraZeneca | 82 | $1,705 |
| Regeneron Healthcare Solutions, Inc. | 27 | $525 |
| Boehringer Ingelheim | 23 | $451 |
| Sanofi | 20 | $328 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $305 |
| Inspire Medical Systems, Inc. | 6 | $219 |
| Axsome Therapeutics, Inc. | 10 | $212 |
| Genentech USA, Inc. | 12 | $210 |
| Grifols USA, LLC | 9 | $180 |
| Abiomed | 1 | $140 |
| United Therapeutics Corporation | 6 | $132 |
| Baxter Healthcare | 4 | $131 |
| Actelion Pharmaceuticals US, Inc. | 6 | $103 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Jazz Pharmaceuticals Inc. | 6 | $97 |
| Lilly USA, LLC | 1 | $90 |
| Mylan Specialty L.p. | 4 | $71 |
| Amgen | 3 | $59 |
| Mallinckrodt Hospital Products Inc. | 2 | $52 |
| Shionogi Inc | 1 | $50 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Insmed, Inc. | 2 | $39 |
| Merck | 2 | $38 |
| Verona Pharma, Inc. | 2 | $37 |
| Bayer | 2 | $34 |
| Viatris Specialty LLC | 2 | $31 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $27 |
| Astellas Pharma US Inc | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Gilead | 1 | $18 |
| Kaleo, Inc. | 1 | $15 |
| Resmed Corp | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,380 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 27 | $358,526 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 239 | $302,070 |
| Prolastin CAlpha-1-Proteinase Inhibitor | 11 | $105,924 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 101 | $85,280 |
| Spiriva RespimatTiotropium Bromide | 58 | $79,803 |
| Breo ElliptaFluticasone/Vilanterol | 101 | $77,643 |
| XolairOmalizumab | 20 | $66,102 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 42 | $42,553 |
| Pirfenidone | 13 | $31,000 |
| SymbicortBudesonide/Formoterol Fumarate | 43 | $23,642 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $12,734 |
| Incruse ElliptaUmeclidinium Bromide | 17 | $11,054 |
| Roflumilast | 70 | $8,384 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 26 | $6,048 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $4,772 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $1,874 | $476,047458 claims |
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $451 | $451,06498 claims |
| Grifols USA, LLCProlastin C | $180 | $105,92411 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,705 | $66,19485 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Middletown
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.